Getting the most out of protein structures: SBDD in the big data era

webinar

Thu, 14 Dec 2017, 16:00 CET (Berlin)

Prof. Dr. Matthias Rarey, Center for Bioinformatics, Hamburg, Germany

Getting the most out of protein structures: SBDD in the big data era

With the availability of more and more protein structures, structure-based design has become a key technology within the early phases of drug design. Protein structures are the only means by which a truly rational design approach gets in sight. While modeling techniques like docking and scoring dealing with small series of protein structures are well established, our methodologies to explore the wealth of information hidden in large collections of protein structures are still rather limited. Most search engines on protein structures are based on text rather than on structural elements, and the analysis of protein structure still requires labor-intense manual steps.

In this talk, new technologies will be presented addressing this opportunity to learn from large structure collections [see doi.org/10.1093/nar/gkx333 and doi.org/10.1016/j.jbiotec.2017.06.004]. On the one hand, the automation of structure preprocessing in the context of drug design plays a crucial role in exploiting large amounts of structural data. On the other hand, search methods allowing to perform geometric queries to structures enable knowledge-driven design decisions. Several examples ranging from interaction geometry analysis, molecular flexibility analysis to design by analogy will be presented.

Current news

category
Events
Announcing BioSolveIT's DrugSpace Symposium 2025: Bridging Science
June 26, 2025 09:43 CEST
We are pleased to announce the fourth edition of the BioSolveIT DrugSpace Symposium, taking place on September 24–25, 2025. This year’s theme, “Bridging Science,” highlights the growing importance of interdisciplinary collaboration in driving innovation across the drug discovery landscape. As the field evolves, it becomes increasingly clear that real progress...
Read on
Psst... Are You Following Us Yet? Follow the Science (and a Bit More)
June 25, 2025 08:44 CEST
There’s a lot going on behind the scenes—ideas taking shape, tools evolving, science in motion. And while the website tells you what our software does, our social media gives you a look at how it lives. We’re active on LinkedIn, BlueSky, and YouTube, sharing everything from scientific snapshots to educational...
Read on
AMBrosia Just Got Bigger: 126 Billion Compound Update Now Available
June 11, 2025 13:21 CEST
We are thrilled to announce a major update to the AMBrosia Chemical Space in collaboration with Ambinter! The state-of-the-art source for diverse drug-like scaffolds now boasts an incredible 126 billion of synthetically accessible compounds for drug discovery projects. What does the update feature? Expanded to an astounding 125,924,571,692 compounds (1.26...
Read on